PERSONALIZED MEDICINE COALITION

HCR · Health Issues

Congressional Personalized Medicine Caucus Senate Rapid Artificial Intelligence (AI) Forum Response to Request for Information: Commonsense Policy Options to Lower Drug Prices for Patients Implementation of the Inflation Reduction Act of 2022 Medicare Drug Price Negotiation Provisions [CMS-4215-P] Medicare and Medicaid Programs; CY 2027 Payment Policies Under the Physician Fee Schedule and Other Changes to Part B Payment and Coverage Policies; Medicare Shared Savings Program Requirements; and Medicare Prescription Drug Inflation Rebate Program [CMS-1848-P] Medicare Program: Hospital Outpatient Prospective Payment and Ambulatory Surgical Center Payment Systems; and Quality Reporting Programs; including the Hospital Outpatient Quality Reporting Program and Ambulatory Surgical Center Quality Program Proposed Rule for Calendar Year 2027 [CMS-1850-P] Leveraging Prior Knowledge in the Development of Human Gene Therapy Products Incorporating Genome Editing; Draft Guidance [FDA-2026-D-1257] Standardizing Laboratory Practices in Pharmacogenomics (STRIPE) Collaborative Community

BUD · Budget/Appropriations

FY 2027 Food and Drug Administration Budget Priorities for CDER, CBER and CDRH FY 2027 National Institutes of Health Budget Priorities Reauthorization of the Prescription Drug User Fee Amendments; PFUFA VIII Reauthorization of the Medical Device User Fee Amendments; MDUFA VI ; Request for Comments [FDA-2026-N-6655] Revising Federal Grant Administration and Uniform Guidance [OMB-2026-0034]